Griffin M Weber, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Electronic Health Records | 19 | 2023 | 4426 | 1.510 |
Why?
|
| Information Storage and Retrieval | 8 | 2019 | 821 | 1.110 |
Why?
|
| Computer Communication Networks | 3 | 2014 | 295 | 0.840 |
Why?
|
| Cell Biology | 2 | 2021 | 92 | 0.780 |
Why?
|
| Medical Record Linkage | 3 | 2021 | 285 | 0.740 |
Why?
|
| Cells | 1 | 2021 | 168 | 0.740 |
Why?
|
| Atlases as Topic | 1 | 2021 | 236 | 0.740 |
Why?
|
| Biomedical Research | 9 | 2017 | 3300 | 0.540 |
Why?
|
| Clinical Laboratory Techniques | 2 | 2018 | 744 | 0.510 |
Why?
|
| Search Engine | 2 | 2015 | 142 | 0.500 |
Why?
|
| Algorithms | 13 | 2023 | 13828 | 0.460 |
Why?
|
| Software | 6 | 2022 | 4425 | 0.460 |
Why?
|
| Cell Lineage | 2 | 2021 | 2498 | 0.440 |
Why?
|
| Privacy | 4 | 2022 | 236 | 0.420 |
Why?
|
| Models, Organizational | 1 | 2015 | 573 | 0.400 |
Why?
|
| Single-Cell Analysis | 1 | 2021 | 2157 | 0.390 |
Why?
|
| Data Collection | 3 | 2023 | 3340 | 0.380 |
Why?
|
| Intracranial Hemorrhages | 5 | 2023 | 846 | 0.360 |
Why?
|
| Hospital Shared Services | 1 | 2009 | 16 | 0.360 |
Why?
|
| Internet | 7 | 2015 | 3048 | 0.340 |
Why?
|
| Medical Records Systems, Computerized | 2 | 2013 | 1205 | 0.340 |
Why?
|
| Information Dissemination | 4 | 2021 | 1106 | 0.300 |
Why?
|
| Pandemics | 3 | 2022 | 8274 | 0.300 |
Why?
|
| Hospital Information Systems | 1 | 2009 | 395 | 0.290 |
Why?
|
| Genetic Markers | 2 | 2004 | 2630 | 0.280 |
Why?
|
| Inpatients | 1 | 2018 | 2478 | 0.280 |
Why?
|
| Research Design | 2 | 2023 | 5959 | 0.270 |
Why?
|
| Bibliometrics | 2 | 2023 | 340 | 0.260 |
Why?
|
| Artificial Intelligence | 3 | 2018 | 2120 | 0.240 |
Why?
|
| User-Computer Interface | 3 | 2012 | 1423 | 0.240 |
Why?
|
| Cooperative Behavior | 1 | 2011 | 1501 | 0.240 |
Why?
|
| Research Personnel | 3 | 2021 | 571 | 0.240 |
Why?
|
| Evidence-Based Medicine | 2 | 2013 | 3606 | 0.240 |
Why?
|
| Enoxaparin | 2 | 2017 | 377 | 0.230 |
Why?
|
| Faculty, Medical | 3 | 2017 | 1179 | 0.230 |
Why?
|
| Career Mobility | 2 | 2016 | 262 | 0.220 |
Why?
|
| Confidentiality | 3 | 2019 | 610 | 0.210 |
Why?
|
| Genetics, Microbial | 1 | 2002 | 60 | 0.210 |
Why?
|
| Health Services Research | 1 | 2009 | 1832 | 0.200 |
Why?
|
| Brain Neoplasms | 5 | 2023 | 8788 | 0.200 |
Why?
|
| Sequence Alignment | 1 | 2005 | 2257 | 0.190 |
Why?
|
| Decision Making | 2 | 2013 | 3854 | 0.190 |
Why?
|
| Information Systems | 2 | 2014 | 410 | 0.190 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 3 | 2004 | 3922 | 0.180 |
Why?
|
| Humans | 62 | 2023 | 739219 | 0.180 |
Why?
|
| Venous Thromboembolism | 3 | 2018 | 1673 | 0.180 |
Why?
|
| Hospitalization | 6 | 2022 | 10208 | 0.180 |
Why?
|
| Computer Graphics | 1 | 2021 | 360 | 0.170 |
Why?
|
| Anticoagulants | 4 | 2022 | 4582 | 0.170 |
Why?
|
| Boston | 5 | 2018 | 9314 | 0.170 |
Why?
|
| Delivery of Health Care | 4 | 2023 | 5272 | 0.160 |
Why?
|
| Phylogeny | 1 | 2005 | 2788 | 0.160 |
Why?
|
| Chromosome Mapping | 2 | 2005 | 4744 | 0.160 |
Why?
|
| National Institutes of Health (U.S.) | 3 | 2021 | 779 | 0.150 |
Why?
|
| Computer Security | 2 | 2021 | 264 | 0.150 |
Why?
|
| Academic Medical Centers | 4 | 2017 | 2749 | 0.150 |
Why?
|
| Insurance Claim Reporting | 1 | 2017 | 163 | 0.150 |
Why?
|
| DNA Mutational Analysis | 1 | 2005 | 4184 | 0.140 |
Why?
|
| Heparin, Low-Molecular-Weight | 1 | 2018 | 341 | 0.140 |
Why?
|
| Sequence Analysis, DNA | 2 | 2005 | 4801 | 0.140 |
Why?
|
| Evolution, Molecular | 1 | 2005 | 1938 | 0.140 |
Why?
|
| Salicylates | 1 | 2016 | 126 | 0.140 |
Why?
|
| Disease | 1 | 2021 | 683 | 0.140 |
Why?
|
| Physicians | 1 | 2013 | 4538 | 0.130 |
Why?
|
| Heart Failure | 1 | 2018 | 10793 | 0.120 |
Why?
|
| Computational Biology | 3 | 2020 | 3513 | 0.120 |
Why?
|
| Financing, Government | 1 | 2017 | 470 | 0.120 |
Why?
|
| Programming Languages | 1 | 2014 | 134 | 0.120 |
Why?
|
| Medical Subject Headings | 1 | 2013 | 15 | 0.120 |
Why?
|
| Intelligence | 2 | 2022 | 919 | 0.120 |
Why?
|
| Organ Transplantation | 1 | 2023 | 1131 | 0.110 |
Why?
|
| Retrospective Studies | 13 | 2023 | 76632 | 0.110 |
Why?
|
| Platelet Aggregation Inhibitors | 2 | 2023 | 3066 | 0.110 |
Why?
|
| Research Support as Topic | 1 | 2017 | 706 | 0.110 |
Why?
|
| PubMed | 1 | 2013 | 121 | 0.110 |
Why?
|
| Health Care Surveys | 2 | 2018 | 2448 | 0.110 |
Why?
|
| Information Seeking Behavior | 1 | 2014 | 112 | 0.110 |
Why?
|
| Diagnostic Tests, Routine | 2 | 2021 | 789 | 0.110 |
Why?
|
| Information Services | 1 | 2014 | 244 | 0.110 |
Why?
|
| Publishing | 2 | 2021 | 828 | 0.110 |
Why?
|
| United States | 13 | 2021 | 69568 | 0.110 |
Why?
|
| Databases, Factual | 5 | 2021 | 7689 | 0.110 |
Why?
|
| Natural Language Processing | 1 | 2020 | 1024 | 0.100 |
Why?
|
| Colonic Neoplasms | 1 | 2023 | 2528 | 0.100 |
Why?
|
| Research | 2 | 2023 | 2001 | 0.090 |
Why?
|
| Databases, Genetic | 3 | 2009 | 1779 | 0.090 |
Why?
|
| Science | 1 | 2013 | 241 | 0.090 |
Why?
|
| Multivariate Analysis | 1 | 2004 | 12235 | 0.090 |
Why?
|
| Universities | 2 | 2014 | 946 | 0.090 |
Why?
|
| Fractures, Compression | 1 | 2011 | 133 | 0.090 |
Why?
|
| Suicide | 1 | 2020 | 1469 | 0.090 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2021 | 3583 | 0.080 |
Why?
|
| Hospital Administration | 1 | 2013 | 354 | 0.080 |
Why?
|
| Fellowships and Scholarships | 1 | 2017 | 1058 | 0.080 |
Why?
|
| Gene Expression Profiling | 2 | 2004 | 9393 | 0.080 |
Why?
|
| Public Policy | 1 | 2013 | 570 | 0.080 |
Why?
|
| Databases, Nucleic Acid | 1 | 2009 | 211 | 0.080 |
Why?
|
| Database Management Systems | 1 | 2010 | 272 | 0.080 |
Why?
|
| Genome, Human | 1 | 2002 | 4424 | 0.080 |
Why?
|
| Medical Informatics | 2 | 2014 | 740 | 0.080 |
Why?
|
| Reproducibility of Results | 3 | 2021 | 19787 | 0.080 |
Why?
|
| Systems Integration | 1 | 2010 | 441 | 0.080 |
Why?
|
| Hospitals | 1 | 2021 | 3916 | 0.080 |
Why?
|
| Child Development Disorders, Pervasive | 1 | 2012 | 615 | 0.070 |
Why?
|
| Logistic Models | 1 | 2002 | 13400 | 0.070 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2016 | 2275 | 0.070 |
Why?
|
| Terminology as Topic | 1 | 2013 | 1548 | 0.070 |
Why?
|
| Middle Aged | 13 | 2023 | 212833 | 0.070 |
Why?
|
| Genomics | 1 | 2021 | 5655 | 0.070 |
Why?
|
| Molecular Biology | 1 | 2009 | 595 | 0.070 |
Why?
|
| Expressed Sequence Tags | 2 | 2004 | 255 | 0.060 |
Why?
|
| PPAR gamma | 1 | 2008 | 494 | 0.060 |
Why?
|
| Adult | 9 | 2023 | 213375 | 0.060 |
Why?
|
| Overweight | 1 | 2016 | 2355 | 0.060 |
Why?
|
| Thiazolidinediones | 1 | 2008 | 474 | 0.060 |
Why?
|
| Models, Theoretical | 3 | 2013 | 3605 | 0.060 |
Why?
|
| Plaque, Atherosclerotic | 1 | 2016 | 1482 | 0.060 |
Why?
|
| Climacteric | 1 | 2004 | 57 | 0.060 |
Why?
|
| Stochastic Processes | 1 | 2005 | 345 | 0.060 |
Why?
|
| Periodicals as Topic | 1 | 2016 | 1428 | 0.060 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 2005 | 1088 | 0.060 |
Why?
|
| Spinal Fractures | 1 | 2011 | 697 | 0.060 |
Why?
|
| Spinal Neoplasms | 1 | 2011 | 758 | 0.060 |
Why?
|
| Phenotype | 1 | 2021 | 16300 | 0.060 |
Why?
|
| ROC Curve | 2 | 2022 | 3524 | 0.060 |
Why?
|
| Patient-Centered Care | 1 | 2014 | 1435 | 0.060 |
Why?
|
| Severity of Illness Index | 1 | 2021 | 15510 | 0.060 |
Why?
|
| Diagnosis | 1 | 2004 | 153 | 0.060 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2022 | 5153 | 0.060 |
Why?
|
| Informatics | 1 | 2023 | 71 | 0.060 |
Why?
|
| Logical Observation Identifiers Names and Codes | 1 | 2022 | 17 | 0.050 |
Why?
|
| Quality Improvement | 1 | 2018 | 3730 | 0.050 |
Why?
|
| Gene Library | 2 | 2004 | 1077 | 0.050 |
Why?
|
| Male | 13 | 2021 | 348967 | 0.050 |
Why?
|
| Female | 16 | 2021 | 378808 | 0.050 |
Why?
|
| Glioma | 1 | 2017 | 3378 | 0.050 |
Why?
|
| Conserved Sequence | 1 | 2005 | 1203 | 0.050 |
Why?
|
| Electronics | 1 | 2023 | 322 | 0.050 |
Why?
|
| Decision Support Systems, Clinical | 1 | 2011 | 1162 | 0.050 |
Why?
|
| Risk Assessment | 2 | 2020 | 23292 | 0.050 |
Why?
|
| Bayes Theorem | 2 | 2020 | 2299 | 0.050 |
Why?
|
| Lung Neoplasms | 2 | 2022 | 12983 | 0.050 |
Why?
|
| Authorship | 1 | 2023 | 268 | 0.050 |
Why?
|
| Mental Disorders | 1 | 2020 | 6570 | 0.050 |
Why?
|
| Neoplasms | 2 | 2015 | 21499 | 0.040 |
Why?
|
| Subtraction Technique | 1 | 2003 | 525 | 0.040 |
Why?
|
| Aged | 7 | 2023 | 162667 | 0.040 |
Why?
|
| Physician-Patient Relations | 1 | 2013 | 3217 | 0.040 |
Why?
|
| Ethics Committees, Research | 1 | 2021 | 194 | 0.040 |
Why?
|
| Cluster Analysis | 2 | 2023 | 2710 | 0.040 |
Why?
|
| Diabetic Retinopathy | 1 | 2008 | 1203 | 0.040 |
Why?
|
| Communication | 1 | 2013 | 3723 | 0.040 |
Why?
|
| RNA, Neoplasm | 1 | 2001 | 760 | 0.040 |
Why?
|
| Hormone Replacement Therapy | 1 | 2004 | 740 | 0.040 |
Why?
|
| Obesity | 2 | 2023 | 12641 | 0.040 |
Why?
|
| Gene Expression | 2 | 2002 | 7789 | 0.040 |
Why?
|
| Pilot Projects | 1 | 2011 | 8272 | 0.040 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2008 | 2037 | 0.040 |
Why?
|
| Genome, Viral | 1 | 2002 | 668 | 0.040 |
Why?
|
| Viruses | 1 | 2002 | 375 | 0.040 |
Why?
|
| Peer Review, Research | 1 | 2021 | 327 | 0.040 |
Why?
|
| Herpesvirus 4, Human | 1 | 2003 | 1038 | 0.040 |
Why?
|
| Chronic Disease | 1 | 2012 | 9132 | 0.040 |
Why?
|
| Registries | 1 | 2012 | 8039 | 0.040 |
Why?
|
| Inflammation | 1 | 2016 | 10531 | 0.040 |
Why?
|
| Government Regulation | 1 | 2021 | 524 | 0.040 |
Why?
|
| DNA, Neoplasm | 1 | 2002 | 1755 | 0.030 |
Why?
|
| Pattern Recognition, Automated | 1 | 2022 | 996 | 0.030 |
Why?
|
| Hypoglycemic Agents | 1 | 2008 | 2861 | 0.030 |
Why?
|
| Genome | 1 | 2004 | 1799 | 0.030 |
Why?
|
| Prognosis | 4 | 2021 | 28901 | 0.030 |
Why?
|
| Molecular Sequence Data | 2 | 2005 | 18124 | 0.030 |
Why?
|
| Sensitivity and Specificity | 2 | 2021 | 14721 | 0.030 |
Why?
|
| Models, Genetic | 1 | 2005 | 3495 | 0.030 |
Why?
|
| DNA, Viral | 1 | 2002 | 2225 | 0.030 |
Why?
|
| Base Sequence | 1 | 2005 | 12807 | 0.030 |
Why?
|
| San Francisco | 1 | 2014 | 159 | 0.030 |
Why?
|
| Diagnosis, Differential | 2 | 2011 | 12945 | 0.030 |
Why?
|
| Retina | 1 | 2004 | 2633 | 0.030 |
Why?
|
| Organizations | 1 | 2014 | 167 | 0.030 |
Why?
|
| Vocabulary, Controlled | 1 | 2014 | 170 | 0.030 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2004 | 3622 | 0.030 |
Why?
|
| Awards and Prizes | 1 | 2017 | 375 | 0.030 |
Why?
|
| Survival Analysis | 2 | 2022 | 10248 | 0.030 |
Why?
|
| Efficiency | 1 | 2015 | 461 | 0.030 |
Why?
|
| Software Design | 1 | 2012 | 175 | 0.030 |
Why?
|
| Sex Ratio | 1 | 2012 | 110 | 0.030 |
Why?
|
| Cohort Studies | 3 | 2023 | 40385 | 0.020 |
Why?
|
| Administration, Oral | 1 | 2018 | 3909 | 0.020 |
Why?
|
| Aspirin | 1 | 2023 | 3268 | 0.020 |
Why?
|
| Models, Statistical | 1 | 2005 | 5108 | 0.020 |
Why?
|
| Carcinoma | 1 | 2002 | 2360 | 0.020 |
Why?
|
| Mammography | 1 | 2002 | 2466 | 0.020 |
Why?
|
| Schools, Medical | 1 | 2017 | 878 | 0.020 |
Why?
|
| Demography | 1 | 2015 | 1650 | 0.020 |
Why?
|
| Online Systems | 1 | 2011 | 184 | 0.020 |
Why?
|
| RNA, Messenger | 2 | 2004 | 13006 | 0.020 |
Why?
|
| Diabetes Mellitus | 1 | 2008 | 5702 | 0.020 |
Why?
|
| Incidence | 2 | 2018 | 20912 | 0.020 |
Why?
|
| Internal Medicine | 1 | 2015 | 996 | 0.020 |
Why?
|
| Young Adult | 3 | 2023 | 56252 | 0.020 |
Why?
|
| Educational Status | 1 | 2016 | 2514 | 0.020 |
Why?
|
| Aged, 80 and over | 3 | 2018 | 57639 | 0.020 |
Why?
|
| Proportional Hazards Models | 1 | 2022 | 12328 | 0.020 |
Why?
|
| Databases, Protein | 1 | 2009 | 382 | 0.020 |
Why?
|
| Odds Ratio | 1 | 2020 | 9846 | 0.020 |
Why?
|
| Neurology | 1 | 2015 | 762 | 0.020 |
Why?
|
| Infant, Newborn | 2 | 2021 | 25470 | 0.020 |
Why?
|
| Adolescent | 3 | 2023 | 85409 | 0.020 |
Why?
|
| Thoracic Vertebrae | 1 | 2011 | 607 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2017 | 6517 | 0.020 |
Why?
|
| Diagnosis, Computer-Assisted | 1 | 2011 | 717 | 0.020 |
Why?
|
| Risk Factors | 3 | 2018 | 71972 | 0.020 |
Why?
|
| Systems Biology | 1 | 2009 | 469 | 0.020 |
Why?
|
| Survival Rate | 2 | 2015 | 12760 | 0.020 |
Why?
|
| Infant | 2 | 2021 | 34923 | 0.020 |
Why?
|
| Anesthesiology | 1 | 2015 | 1043 | 0.020 |
Why?
|
| Child, Preschool | 2 | 2021 | 40801 | 0.020 |
Why?
|
| Breast Neoplasms | 2 | 2002 | 20672 | 0.020 |
Why?
|
| Time Factors | 3 | 2018 | 40040 | 0.020 |
Why?
|
| Macular Edema | 1 | 2008 | 359 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2011 | 35274 | 0.010 |
Why?
|
| Bromodeoxyuridine | 1 | 2004 | 324 | 0.010 |
Why?
|
| Adenocarcinoma | 1 | 2001 | 6319 | 0.010 |
Why?
|
| General Surgery | 1 | 2015 | 1630 | 0.010 |
Why?
|
| Follow-Up Studies | 2 | 2016 | 38941 | 0.010 |
Why?
|
| Child | 3 | 2021 | 77029 | 0.010 |
Why?
|
| Sex Factors | 1 | 2017 | 10397 | 0.010 |
Why?
|
| Quality of Life | 1 | 2004 | 12640 | 0.010 |
Why?
|
| Psychiatry | 1 | 2015 | 1686 | 0.010 |
Why?
|
| Medical Records | 1 | 2008 | 1413 | 0.010 |
Why?
|
| Double-Blind Method | 1 | 2016 | 11985 | 0.010 |
Why?
|
| Risk Reduction Behavior | 1 | 2008 | 1123 | 0.010 |
Why?
|
| Neoplasm Metastasis | 2 | 2002 | 4832 | 0.010 |
Why?
|
| Radiology | 1 | 2015 | 2080 | 0.010 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2016 | 3233 | 0.010 |
Why?
|
| Mathematics | 1 | 2002 | 728 | 0.010 |
Why?
|
| Diabetes Complications | 1 | 2008 | 1356 | 0.010 |
Why?
|
| Markov Chains | 1 | 2004 | 968 | 0.010 |
Why?
|
| Open Reading Frames | 1 | 2004 | 810 | 0.010 |
Why?
|
| North America | 1 | 2004 | 1249 | 0.010 |
Why?
|
| Neoplasm Staging | 1 | 2015 | 10961 | 0.010 |
Why?
|
| Pediatrics | 1 | 2015 | 3454 | 0.010 |
Why?
|
| In Situ Hybridization | 1 | 2004 | 1938 | 0.010 |
Why?
|
| Animals | 3 | 2009 | 168358 | 0.010 |
Why?
|
| Interneurons | 1 | 2004 | 574 | 0.010 |
Why?
|
| DNA, Complementary | 1 | 2003 | 2049 | 0.010 |
Why?
|
| Carcinoma, Small Cell | 1 | 2001 | 418 | 0.010 |
Why?
|
| Visual Acuity | 1 | 2008 | 2517 | 0.010 |
Why?
|
| Mitosis | 1 | 2004 | 1213 | 0.010 |
Why?
|
| Neuroglia | 1 | 2004 | 928 | 0.010 |
Why?
|
| Disease Progression | 2 | 2008 | 13237 | 0.010 |
Why?
|
| Quality-Adjusted Life Years | 1 | 2004 | 1689 | 0.010 |
Why?
|
| Life Expectancy | 1 | 2004 | 1208 | 0.010 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2012 | 2397 | 0.010 |
Why?
|
| Comorbidity | 1 | 2012 | 10362 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2015 | 21691 | 0.010 |
Why?
|
| Prevalence | 1 | 2012 | 15152 | 0.010 |
Why?
|
| Neoplasm Invasiveness | 1 | 2002 | 3599 | 0.010 |
Why?
|
| Decision Support Techniques | 1 | 2004 | 1957 | 0.010 |
Why?
|
| Carcinoma, Ductal, Breast | 1 | 2002 | 1100 | 0.010 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2008 | 3323 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 2003 | 6176 | 0.010 |
Why?
|
| Models, Biological | 1 | 2009 | 9598 | 0.010 |
Why?
|
| Mortality | 1 | 2004 | 2851 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2018 | 62691 | 0.010 |
Why?
|
| Longitudinal Studies | 1 | 2008 | 13880 | 0.010 |
Why?
|
| Risk | 1 | 2004 | 9684 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2016 | 53036 | 0.010 |
Why?
|
| Stem Cells | 1 | 2004 | 3571 | 0.010 |
Why?
|
| Mass Screening | 1 | 2002 | 5265 | 0.000 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2001 | 4013 | 0.000 |
Why?
|
| Gene Expression Regulation | 1 | 2004 | 12064 | 0.000 |
Why?
|
| Smoking | 1 | 2001 | 8959 | 0.000 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2008 | 11699 | 0.000 |
Why?
|
| Mice | 1 | 2004 | 80995 | 0.000 |
Why?
|